196300 — Anygen Co Balance Sheet
0.000.00%
HealthcareSpeculativeMicro CapSucker Stock
- KR₩37bn
- KR₩43bn
- KR₩9bn
Annual balance sheet for Anygen Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 10,485 | 6,470 | 7,091 | 5,739 | 1,480 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1,118 | 895 | 1,341 | 2,401 | 1,469 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 13,879 | 9,342 | 10,642 | 11,693 | 8,137 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 19,190 | 18,967 | 17,923 | 16,742 | 15,840 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 35,424 | 30,732 | 31,237 | 32,415 | 25,888 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 2,544 | 2,499 | 15,928 | 11,398 | 11,281 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 14,030 | 15,739 | 18,992 | 12,812 | 12,492 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 21,394 | 14,993 | 12,245 | 19,603 | 13,396 |
Total Liabilities & Shareholders' Equity | 35,424 | 30,732 | 31,237 | 32,415 | 25,888 |
Total Common Shares Outstanding |